z-logo
Premium
Successful treatment with placenta‐derived decidual stromal cells in a pediatric patient with life‐threatening acute gastrointestinal graft‐versus‐host disease
Author(s) -
Gustafsson Britt,
Frisk Per,
Szakos Attilla,
Sadeghi Behnam,
Ringdén Olle,
Frost BrittMarie
Publication year - 2017
Publication title -
pediatric transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 69
eISSN - 1399-3046
pISSN - 1397-3142
DOI - 10.1111/petr.12990
Subject(s) - medicine , stromal cell , disease , complication , placenta , graft versus host disease , pregnancy , gastrointestinal tract , immunology , gastroenterology , fetus , biology , genetics
Severe aGv HD is a life‐threatening complication after allogeneic HSCT . The GI tract is considered to play a key role in aGvHD , where the disease process can start and is one of the major target organs. Here, we present a case of a one‐year‐old child with a life‐threatening GI ‐ aGvHD stage IV , post‐ HSCT , resistant to steroids and MMF for 4 weeks. He was successfully treated with placenta‐derived DSC.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom